RTTNews | Sep 29, 2021 11:12AM EDT

11:11 Wednesday, September 29, 2021 (RTTNews.com) - NuCana Plc (NCNA) shares are surging on Wednesday morning trade after the said it received fast track designation from FDA for Acelarin for the treatment of biliary tract cancer. The investigative drug compound is currently pursued in the phase 3 study.

FDA's fast track is a process designed to facilitate the development, and expedite the review of drugs to treat serious conditions and fill an unmet medical need.

Currently, shares are at $3.07, up 29.93 percent from the previous close of $2.37 on a volume of 65,045,094. For the 52-week period, the shares have traded in a range of $1.88-$7.83 on average volume of 357,739.

Read the original article on RTTNews ( https://www.rttnews.com/3229141/nucana-shares-above-21-on-fast-track-designation-for-acelarin-to-treat-biliary-tract-cancer.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved